" class="no-js "lang="en-US"> ConcertAI Archives - Medtech Alert
Friday, June 21, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Quality Cancer Care Alliance (QCCA) and ConcertAI Partner on Novel Digital Clinical Trial Solutions, Accelerating Patient Access to Clinical Trials

ConcertAI, LLC (ConcertAI), a market leader for Real-World Evidence (RWE) and enterprise AI Software-as-a-Service (SaaS) […]

ConcertAI Names Catherine Richards as its First Chief Data Officer and RWD Products Head

ConcertAI, LLC (ConcertAI), a market leader for real-world data (RWD) and enterprise AI technology solutions […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more